Inventor · disambiguated record
Pamela Tan
Also filed as: TAN PAMELA
58 granted patents·32 pending applications·1,150 citations·filing 2002–2024
99Inventor score
Files withALNYLAM PHARMACEUTICALS INC48ARROWHEAD PHARMACEUTICALS INC5NAKAYAMA TOMOKO4TAN PAMELA4BUMCROT DAVID3
Top patents by PatentIndex Score
90 records- 0199US7749978B2Compositions and methods for inhibiting expression of Huntingtin geneALNYLAM PHARMACEUTICALS INC·Filed 2007·Granted Jul 6, 2010·113 cites·26 claims
- 0299US7718629B2Compositions and methods for inhibiting expression of Eg5 geneALNYLAM PHARMACEUTICALS INC·Filed 2007·Granted May 18, 2010·241 cites·33 claims
- 0399US7605251B2Compositions and methods for inhibiting expression of the PCSK9 geneALNYLAM PHARMACEUTICALS INC·Filed 2007·Granted Oct 20, 2009·160 cites·20 claims
- 0499US7582745B2Compositions and methods for inhibiting expression of Nav1.8 geneALNYLAM PHARMACEUTICALS INC·Filed 2006·Granted Sep 1, 2009·152 cites·11 claims
- 0599US7320965B2Compositions and methods for inhibiting expression of Huntingtin geneALNYLAM PHARMACEUTICALS INC·Filed 2006·Granted Jan 22, 2008·208 cites·8 claims
- 0696US7718632B2RNAi inhibition of alpha-ENaC expressionNOVARTIS AG·Filed 2008·Granted May 18, 2010·24 cites·27 claims
- 0795US7943592B2RNAi inhibition of alpha-ENaC expressionNOVARTIS AG·Filed 2010·Granted May 17, 2011·18 cites·20 claims
- 0895US7939508B2RNAi inhibition of alpha-ENaC expressionNOVARTIS AG·Filed 2010·Granted May 10, 2011·18 cites·23 claims
- 0994US8124752B2Compositions and methods for inhibiting expression of the MYC geneBUMCROT DAVID·Filed 2007·Granted Feb 28, 2012·37 cites·8 claims
- 1093US8470799B2Compositions and methods for inhibiting expression of the HAMP geneNAKAYAMA TOMOKO·Filed 2012·Granted Jun 25, 2013·9 cites·20 claims
- 1193US8268799B2Compositions and methods for inhibiting expression of the HAMP geneNAKAYAMA TOMOKO·Filed 2011·Granted Sep 18, 2012·10 cites·24 claims
- 1293US8168606B2RNAi inhibition of alpha-ENaC expressionVAN HEEKE GINO·Filed 2010·Granted May 1, 2012·15 cites·23 claims
- 1392US8791250B2Compositions and methods for inhibiting expression of the HAMP geneALNYLAM PHARMACEUTICALS INC·Filed 2013·Granted Jul 29, 2014·7 cites·20 claims
- 1492US8222222B2Compositions and methods for inhibiting expression of the PCSK9 geneTAN PAMELA·Filed 2009·Granted Jul 17, 2012·13 cites·27 claims
- 1592US2025171785A1Compositions and methods for inhibiting expression of the pcsk9 geneALNYLAM PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 1691US9212364B2Compositions and methods for inhibiting expression of mutant EGFR geneSAH DINAH·Filed 2012·Granted Dec 15, 2015·24 cites·21 claims
- 1789US9260718B2Compositions and methods for inhibiting expression of the PCSK9 geneALNYLAM PHARMACEUTICALS INC·Filed 2014·Granted Feb 16, 2016·6 cites·27 claims
- 1889US8809292B2Compositions and methods for inhibiting expression of the PCSK9 geneTAN PAMELA·Filed 2012·Granted Aug 19, 2014·7 cites·38 claims
- 1989US7691824B2Compositions and methods for inhibiting expression of a gene from the JC virusALNYLAM PHARMACEUTICALS INC·Filed 2007·Granted Apr 6, 2010·8 cites·15 claims
- 2087US9822365B2Compositions and methods for inhibiting expression of the PCSK9 geneALNYLAM PHARMACEUTICALS INC·Filed 2016·Granted Nov 21, 2017·3 cites·34 claims
- 2187US9074212B2RNAi inhibition of alpha-ENaC expressionVAN HEEKE GINO·Filed 2010·Granted Jul 7, 2015·6 cites·20 claims
- 2287US8119612B2RNAi inhibition of alpha-ENaC expressionVAN HEEKE GINO·Filed 2010·Granted Feb 21, 2012·6 cites·23 claims
- 2387US7759320B2Compositions and methods for inhibiting expression of a gene from the EbolaALNYLAM PHARMACEUTICALS INC·Filed 2008·Granted Jul 20, 2010·6 cites·21 claims
- 2487US2024093199A1Compositions and methods for inhibiting expression of the pcsk9 geneALNYLAM PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 2586US2024401060A1Compositions and methods for inhibiting expression of mutant egfr geneALNYLAM PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 2685US8163711B2Compositions and methods for inhibiting expression of the HAMP geneNAKAYAMA TOMOKO·Filed 2010·Granted Apr 24, 2012·5 cites·19 claims
- 2784US9476052B2RNAi inhibition of alpha-ENaC expressionARROWHEAD RES CORP·Filed 2015·Granted Oct 25, 2016·2 cites·20 claims
- 2884US7323327B2Genes encoding novel proteolytic enzymesDSM IP ASSETS BV·Filed 2002·Granted Jan 29, 2008·28 cites·25 claims
- 2982US8227188B2Enhancement of influenza gene expressionDE FOUGEROLLES ANTONIN·Filed 2010·Granted Jul 24, 2012·4 cites·19 claims
- 3082US2022235361A1RNAi Inhibition of Alpha-ENaC ExpressionARROWHEAD PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 3181US10544418B2RNAi inhibition of alpha-ENaC expressionARROWHEAD PHARMACEUTICALS INC·Filed 2018·Granted Jan 28, 2020·1 cites·13 claims
- 3281US10501742B2Compositions and methods for inhibiting expression of the PCSK9 geneALNYLAM PHARMACEUTICALS INC·Filed 2017·Granted Dec 10, 2019·1 cites·19 claims
- 3381US9090895B2Compositions and methods for inhibiting expression of the HAMP geneALNYLAM PHARMACEUTICALS INC·Filed 2014·Granted Jul 28, 2015·1 cites·20 claims
- 3481US8080532B2Compositions and methods for inhibiting expression of Huntingtin geneSAH DINAH WEN-YEE·Filed 2009·Granted Dec 20, 2011·2 cites·24 claims
- 3581US2022112505A1RNAi Inhibition of Alpha-ENaC ExpressionARROWHEAD PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 3679US2023053332A1Compositions and methods for inhibiting expression of mutant egfr geneALNYLAM PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 3778US2021403917A1Compositions and methods for inhibiting expression of the pcsk9 geneALNYLAM PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 3878US2020318119A1Compositions and Methods for Inhibiting Expression of the PCSK9 GeneALNYLAM PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
- 3977US8058257B2Compositions and methods for inhibiting expression of a gene from the JC virusTAN PAMELA·Filed 2010·Granted Nov 15, 2011·2 cites·16 claims
- 4077US7846908B2RNAi modulation of TGF-beta and therapeutic uses thereofALNYLAM PHARMACEUTICALS INC·Filed 2007·Granted Dec 7, 2010·2 cites·32 claims
- 4177US7772200B2iRNA agents targeted to the Rho-A geneALNYLAM PHARMACEUTICALS INC·Filed 2006·Granted Aug 10, 2010·2 cites·5 claims
- 4276US11208662B2RNAi inhibition of alpha-ENaC expressionARROWHEAD PHARMACEUTICALS INC·Filed 2020·Granted Dec 28, 2021·0 cites·21 claims
- 4375US7902168B2Compositions and methods for inhibiting expression of Nav1.8 geneALNYLAM PHARMACEUTICALS INC·Filed 2009·Granted Mar 8, 2011·1 cites·11 claims
- 4474US8735369B2Compositions and methods for inhibiting expression of a gene from the Ebola virusALNYLAM PHARMACEUTICALS INC·Filed 2012·Granted May 27, 2014·1 cites·17 claims
- 4574US8288525B2Compositions and methods for inhibiting expression of CD45 geneDE FOUGEROLLES ANTONIN·Filed 2009·Granted Oct 16, 2012·1 cites·14 claims
- 4674US7737266B2RNAi modulation of SCAP and therapeutics uses thereofUNIV TEXAS·Filed 2007·Granted Jun 15, 2010·1 cites·18 claims
- 4773US12201394B2Apparatus and method for protecting an operating fieldMEDSTAR HEALTH INC·Filed 2023·Granted Jan 21, 2025·0 cites·10 claims
- 4873US7956177B2dsRNA compositions and methods for treating HPV infectionALNYLAM PHARMACEUTICALS INC·Filed 2007·Granted Jun 7, 2011·1 cites·20 claims
- 4973US7812150B2RNAi modulation of Aha and therapeutic uses thereofALNYLAM PHARMACEUTICALS INC·Filed 2007·Granted Oct 12, 2010·1 cites·14 claims
- 5072US9102940B2RNAi modulation of SCAP and therapeutic uses thereofALNYLAM PHARMACEUTICALS INC·Filed 2013·Granted Aug 11, 2015·1 cites·12 claims
Showing the top 50 of 90 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Pamela Tan files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →